Clinical trial
Multi-center, Randomized Trial With I.V. Prolastin® to Evaluate Frequency of Exacerbations and Progression of Emphysema by Means of Multi-slice CT Scans in Patients With Congenital Alpha-1-antitrypsin Deficiency.
NCT00263887 is registered in ClinicalTrials.gov with Grifols Therapeutics LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center, Randomized Trial With I.V. Prolastin® to Evaluate Frequency of Exacerbations and Progression of Emphysema by Means of Multi-slice CT Scans in Patients With Congenital Alpha-1-antitrypsin Deficiency.
- Lead sponsor
- Grifols Therapeutics LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- January 31, 2007
- Enrollment
- 77 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.